Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a random...

by DuBiner, Harvey B, Hubatsch, Douglas A
Published 2014

Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study

by Altafini, Romeo, Scherzer, Maria-Luise, Hubatsch, Douglas A, Frezzotti, Paolo
Published 2015

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma

by Hommer, Anton, Hubatsch, Douglas A., Cano-Parra, Juan
Published 2015

Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study

by Lopes, Joao F., Hubatsch, Douglas A., Amaris, Patricia
Published 2015

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

by Schnober, Dietmar, Hubatsch, Douglas A, Scherzer, Maria-Luise
Published 2015

Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost

by García-Feijoo, Julian, Muñoz-Negrete, Francisco J, Hubatsch, Douglas A, Rossi, Gemma C
Published 2016